Inactivation of SARS‐CoV‐2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is unlikely to be a major transfusion‐transmitted pathogen; however, convalescent plasma is a treatment option used in some regions. The risk of transfusion‐transmitted infections can be minimized by implementing Pathogen Inact...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobson‐Peters, Jody, Amarilla, Alberto A., Rustanti, Lina, Marks, Denese C., Roulis, Eileen, Khromykh, Alexander A., Modhiran, Naphak, Watterson, Daniel, Reichenberg, Stefan, Tolksdorf, Frank, Sumian, Chryslain, Seltsam, Axel, Gravemann, Ute, Faddy, Helen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880728/
https://www.ncbi.nlm.nih.gov/pubmed/36573801
http://dx.doi.org/10.1111/trf.17238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880728/
https://www.ncbi.nlm.nih.gov/pubmed/36573801
http://dx.doi.org/10.1111/trf.17238

Ejemplares similares